MLchartDataset catalogue

encochleated amphotericin B

Term · Oncology and biomedicine · MLC-T-ONC-013337

A proprietary, orally bioavailable, nanoparticle-based encochleated formulation composed of amphotericin B, a polyene antifungal antibiotic produced by Streptomyces nodosus, encochleated within lipid-based crystals, which are composed of multi-layered, rolled-up sheets of soy-derived phosphatidylserine (PS) bilayers and calcium, with broad-spectrum antifungal activity. Upon oral administration, the cochleate crystal structure protects amphotericin B from degradation within the gastrointestinal (GI) tract. The lipid structure facilitates uptake into the bloodstream where the nanoparticles are taken up by macrophages and fungal cells though phagocytosis. Amphotericin B is released from the cochleate due to the calcium differential between the inside of the cell, which has low calcium levels, and the outside of the cell, which has high calcium levels. This delivers amphotericin B directly to the fungal-infected site and to its target cells. In turn, amphotericin B binds to ergosterol, an essential component of the fungal cell membrane. This results in depolarization of the cell membrane, alterations in cell membrane permeability, leakage of important intracellular components, and cell rupture. This causes fungal cell death and prevents fungal infections. Compared to amphotericin B alone, which can only be administered intravenously (IV), this formulation permits oral administration and reduces treatment-limiting side effects that are seen with IV amphotericin B, particularly nephro- and hepato-toxicity.

Table 1. Record
IdentifierMLC-T-ONC-013337
FieldOncology and biomedicine
AbbreviationCAMB
Synonymsoral encochleated amphotericin B; lipid-crystal nanoparticle-based amphotericin B formulation; lipid-crystal nano-particle formulation of amphotericin B; nano-cochleated-particles containing amphotericin B; cochleate-amphotericin B; cochleate lipid-crystal nano-particles-containing amphotericin B
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013337",
  "term": "encochleated amphotericin B",
  "field": "Oncology and biomedicine",
  "definition": "A proprietary, orally bioavailable, nanoparticle-based encochleated formulation composed of amphotericin B, a polyene antifungal antibiotic produced by Streptomyces nodosus, encochleated within lipid-based crystals, which are composed of multi-layered, rolled-up sheets of soy-derived phosphatidylserine (PS) bilayers and calcium, with broad-spectrum antifungal activity. Upon oral administration, the cochleate crystal structure protects amphotericin B from degradation within the gastrointestinal (GI) tract. The lipid structure facilitates uptake into the bloodstream where the nanoparticles are taken up by macrophages and fungal cells though phagocytosis. Amphotericin B is released from the cochleate due to the calcium differential between the inside of the cell, which has low calcium levels, and the outside of the cell, which has high calcium levels. This delivers amphotericin B directly to the fungal-infected site and to its target cells. In turn, amphotericin B binds to ergosterol, an essential component of the fungal cell membrane. This results in depolarization of the cell membrane, alterations in cell membrane permeability, leakage of important intracellular components, and cell rupture. This causes fungal cell death and prevents fungal infections. Compared to amphotericin B alone, which can only be administered intravenously (IV), this formulation permits oral administration and reduces treatment-limiting side effects that are seen with IV amphotericin B, particularly nephro- and hepato-toxicity.",
  "abbreviation": "CAMB",
  "synonyms": [
    "oral encochleated amphotericin B",
    "lipid-crystal nanoparticle-based amphotericin B formulation",
    "lipid-crystal nano-particle formulation of amphotericin B",
    "nano-cochleated-particles containing amphotericin B",
    "cochleate-amphotericin B",
    "cochleate lipid-crystal nano-particles-containing amphotericin B"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/encochleated-amphotericin-b/"
}

Record 6,619 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.